Esrd

Administrators of independent dialysis clinics said in a letter to Congressional leaders that intervention is needed to avoid staffing cuts because of inadequate Medicare payments.

Patients with chronic kidney disease are at high risk for adverse cardiovascular events, even after adjusting for traditional risk factors.

When nephrologists direct care for patients with kidney disease, many comorbid-related issues are addressed in a patient care plan, including fluid overload, access patency, anemia management and phosphorus control.

CMS has a history of using ‘financial carrots’ to influence treatment approaches in the ESRD Program.

In September 2020, CMS published the final rule for ESRD Treatment Choices, a new demonstration designed to test incentives for increasing use of home dialysis and kidney transplantation for patients with end-stage kidney disease.

According to the National Kidney Foundation, 1:7 people in the United States – about 15% of the adult population – have some form of chronic kidney disease.

On Sept. 18, CMS released its final rule for the End-Stage Renal Disease Treatment Choices model, covering kidney care providers across nearly one-third of the United States.

Kidney care has long been a particular pain point in the health care system, but reform is on the way.

On July 18, 2019, CMS proposed ESRD Treatment Choices, a new payment model for the kidney care community aimed at increasing use of home dialysis and kidney transplantation.

The National Renal Administrators Association is asking CMS to delay the planned Jan. 1 launch of the ESRD Treatment Choices model until after the COVID-19 pandemic ends, giving dialysis providers time to prepare for the demonstration.